Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the addition of Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel, as an additional clinical site for its ongoing Phase I/IIa clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This expansion follows the recent enrollment of the first patient in the trial, announced on June 5, 2025, marking a …

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“Impact BioMedical”) (NYSE American: IBO), a Texas based biopharmaceuticals developer listed on the New York Stock Exchange American (“Impact BioMedical”, together with Dr Ashleys, the “Parties”), are pleased to announce the execution of a merger and share exchange agreement (the “Merger Agreement”) on June 21, 2025 to enter into a strategic merger transaction (the “Transaction”). Upon closing of the Transaction, Dr. Ashleys will acquire Impact BioMedical through a reverse merger that will result in a newly …

HOUSTON--(BUSINESS WIRE)--Crescent Energy Company (NYSE: CRGY) (“we” or “our”) announced today that, subject to market conditions, its indirect subsidiary Crescent Energy Finance LLC (the “Issuer”) intends to offer for sale in a private placement pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”), to eligible purchasers, $500 million aggregate principal amount of Senior Notes due 2034 (the “Notes”). The Notes will be guaranteed on a senior.

Heavy exposure to Japan in the Schwab International Equity ETF poses potential risks due to emerging issues in the Japanese market, prompting a reassessment of my earlier outlook. The SPDR® Portfolio Europe ETF offers broad European diversification, low fees (0.07%), and a solid dividend yield, making it an attractive international alternative. SPEU's sector and country allocations reduce concentration risk, with strong representation in the UK, France, and Germany.

Novo Nordisk said on Monday it would halt its collaboration with Hims & Hers Health over the sale of weight loss drugs.

Ouster remains my top pick in LiDAR, with strong financials, broad customer base, and a clear path to profitability by 2027. Aeva's valuation is overextended, trading at 30x 2026 revenue despite lower sales, higher cash burn, and later profitability than Ouster. Sylebra's backing is the main driver of Aeva's stock rally, but fundamentals need to catch up to the valuation with a $1.38B market cap.

Viral Sharing of AI COMIC on TikTok and Facebook Signals Strong User Adoption and Community Engagement User Base in Japan and South Korea Grows 1,300%, Underscoring Commercial Success and Global Potential Cutting-Edge AI Capabilities and Smart Cloud Infrastructure are Foundation for Growth VANCOUVER, BC , June 23, 2025 /PRNewswire/ -- Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW) ("Siyata" or the "Company"), a global developer and vendor of mission-critical Push-to-Talk over Cellular (PoC) handsets and accessories, today announced that Core Gaming, a rising innovator in AI-driven creative technologies, who it recently signed a definitive merger agreement with, is experiencing continued momentum with …

As we hit the halfway point of 2025, the year has proven anything but calm. Markets have faced several challenges, from geopolitical tensions and new tariffs to potential shifts in fiscal and monetary policy.

Granite Ridge Resources, Inc. (GRNT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

12 of 13 participants maintained or lost weight at 3 months, with 6 of 13 losing additional weight after stopping GLP-1 therapy and undergoing Revita procedure

Victoria Greene, CIO of G Squared Private Wealth, sees markets pricing in a contained Iran response, warns of oil shocks if Strait of Hormuz closes, and favors energy, defense, and US dip-buying.

Don't bet on fads, invest in fundamentals for lasting, resilient income streams in any market. Your portfolio should be the fortress guarding your financial independence. We discuss our top energy infrastructure picks with yields of up to 9%.

HOUSTON--(BUSINESS WIRE)--Tidewater Inc. (NYSE: TDW) (“Tidewater” or “the Company”) today announced that it has commenced a private offering (the “Offering”) of $650 million in aggregate principal amount of unsecured senior notes due 2030 (the “2030 Notes”). The Company expects to use the net proceeds from the Offering, together with cash on hand, (i) to repay in full the Company's existing senior secured term loan, (ii) to fund the redemption (the “Redemption”) of both the Company's outstandin.

The ITC compared all published Phase 3 data of these treatments, leveraging longitudinal results, and findings reinforce the importance of consistent, sustained disease control in managing a chronic autoantibody disease like gMG IMAAVY, an FcRn blocker, received U.S. FDA approval earlier this year for the broadest population of individuals living with gMG, including anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older SPRING HOUSE, Pa. , June 23, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new data from an indirect treatment comparison (ITC) that showed consistent and sustained disease control with IMAAVY™ …

Markets remain volatile, with inflation and rates staying "higher for longer." Geopolitical tensions and policy risks keep uncertainty high for investors. I'm focusing on undervalued dividend stocks that provide solid inflation protection and growth potential despite cyclical pressures and macro challenges. With risks rising, deep-value dividend stocks that can navigate inflation and market volatility offer a strong way to build resilience in uncertain times.

PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly-owned subsidiary of Ocugen, Inc. (Nasdaq: OCGN) (Ocugen), a clinical-stage company developing regenerative cell therapies for orthopedic diseases, today jointly announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on the development of OrthoCellix's NeoCart® technology for the treatment of knee articular cartilage defects and plans to initiate a U.S. Food and Drug Administration (FDA)-endorsed Phase 3 clinical trial for NeoCart®.

I see LegalZoom as a compelling small-cap value play, especially as large-cap valuations look stretched amid macro uncertainty. LegalZoom's accelerating revenue growth, expanding subscriber base, and flat expenses are driving significant profit expansion, yet the market hasn't recognized this turnaround. The company is shifting toward recurring subscription revenue, boasts strong retention, and has a large buyback authorization supported by a robust net cash position.

Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Basal Cell Carcinoma (BCC) Using Novel Doxorubicin Containing Microneedle Arrays (D-MNA) Philadelphia, Pennsylvania--(Newsfile Corp. - June 23, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce the appointment of Andrew Smith as Chief Operating Officer.

Vancouver, Canada--(Newsfile Corp. - June 23, 2025) - Turnium Technology Group Inc. (TSXV: TTGI) (FSE: E48) ("TTGI" or "the Company"), a global leader in Technology-as-a-Service (TaaS) and partner enablement services, including an AI-powered prospecting and lead generation platform, is pleased to announce a major strategic alliance with Toronto-based Syntheia Corp. (CSE: SYAI), a pioneering conversational AI company. This partnership will see Syntheia AI join TTGI's global supplier resource pool, bringing advanced AI expertise to strengthen TTGI's internal technical, marketing, and partner delivery capabilities across its worldwide network of over 70 channel partners.

NEW YORK , June 23, 2025 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE), the creator and leader of the modern ground lease industry, has closed on the acquisition of an existing ground lease beneath the Asher Adams hotel in Downtown Salt Lake City. Developed through a partnership between The Athens Group and Hatteras Sky, the 225-key, full-service hotel was completed in 2024 and operates as part of Marriott's Autograph Collection.